Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqac094
Abstract: Abstract Objectives Eltrombopag, a thrombopoietin-receptor agonist, stimulates hematopoiesis in patients with acquired aplastic anemia (AA). Cytomorphologic changes in bone marrow after eltrombopag administration are still unclear. This study examined the effect of eltrombopag on cytomorphologic… read more here.
Keywords: bone marrow; dysmegakaryopoiesis; eltrombopag; hematologic improvement ... See more keywords